The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.
In plain words A study of betalains in people 18 to 40, run by Drexel University. It plans to enroll about 10 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 40; healthy volunteers accepted. Conditions: Nutraceuticals.
- Healthy, recreationally active males and females
- Aged 18-40
- Free of disease or injury
The exclusion criteria are on the listing.
What it tests, as registered
Betalain-rich concentrate (AltRed); Placebo
Registered summary
Betalains have well-known antioxidant and anti-inflammatory properties. Recent investigations examining the effects of a betalain-rich concentrate (BRC) on exercise and recovery performance show promise of BRC as an ergogenic aid. To date, no study has examined the effects of a single dose of a BRC on supramaximal performance and recovery. Therefore, the purpose of this study is to examine the effects of an acute dose of BRC on repeated-sprint cycling performance and recovery.
Where, as registered
1 US site in 1 state.